Revenio Group Oyj (0KFH.L)
EUR 22.5
(-6.25%)
EUR 22.5
(-6.25%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 10.05 Million EUR | -33.51% |
| 2022 | 15.11 Million EUR | 1577.58% |
| 2021 | 901 Thousand EUR | -95.91% |
| 2020 | 22.03 Million EUR | -8.89% |
| 2019 | 24.18 Million EUR | 13640.91% |
| 2018 | 176 Thousand EUR | -45.68% |
| 2017 | 324 Thousand EUR | -55.68% |
| 2016 | 731 Thousand EUR | 52.29% |
| 2015 | 480 Thousand EUR | -37.9% |
| 2014 | 773 Thousand EUR | -40.77% |
| 2013 | 1.3 Million EUR | -4.47% |
| 2012 | 1.36 Million EUR | 185.77% |
| 2011 | 478 Thousand EUR | -67.44% |
| 2010 | 1.46 Million EUR | -46.23% |
| 2009 | 2.73 Million EUR | 23.14% |
| 2008 | 2.21 Million EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 7.6 Million EUR | 0.0% |
| 2024 Q2 | 8.7 Million EUR | 0.0% |
| 2024 Q1 | 2 Million EUR | -100.0% |
| 2023 Q3 | 1.7 Million EUR | -15.0% |
| 2023 Q1 | 800 Thousand EUR | -94.71% |
| 2023 Q4 | 10.8 Million EUR | 535.29% |
| 2023 FY | 10.05 Million EUR | -33.51% |
| 2023 Q2 | 2 Million EUR | 150.0% |
| 2022 Q2 | 1.1 Million EUR | 37.5% |
| 2022 FY | 15.11 Million EUR | 1577.58% |
| 2022 Q1 | 800 Thousand EUR | -11.21% |
| 2022 Q4 | 15.11 Million EUR | -11.61% |
| 2022 Q3 | 17.1 Million EUR | 1454.55% |
| 2021 Q3 | 500 Thousand EUR | 25.0% |
| 2021 Q2 | 400 Thousand EUR | 33.33% |
| 2021 Q4 | 901 Thousand EUR | 80.2% |
| 2021 Q1 | 300 Thousand EUR | -98.64% |
| 2021 FY | 901 Thousand EUR | -95.91% |
| 2020 Q2 | 25.8 Million EUR | -0.39% |
| 2020 Q4 | 22.03 Million EUR | 4307.0% |
| 2020 FY | 22.03 Million EUR | -8.89% |
| 2020 Q1 | 25.9 Million EUR | 7.1% |
| 2020 Q3 | 500 Thousand EUR | -98.06% |
| 2019 FY | 24.18 Million EUR | 13640.91% |
| 2019 Q1 | 600 Thousand EUR | 240.91% |
| 2019 Q3 | 27.7 Million EUR | -0.36% |
| 2019 Q2 | 27.8 Million EUR | 4533.33% |
| 2019 Q4 | 24.18 Million EUR | -12.69% |
| 2018 FY | 176 Thousand EUR | -45.68% |
| 2018 Q3 | 200 Thousand EUR | -33.33% |
| 2018 Q2 | 300 Thousand EUR | 0.0% |
| 2018 Q1 | 300 Thousand EUR | -7.41% |
| 2018 Q4 | 176 Thousand EUR | -12.0% |
| 2017 FY | 324 Thousand EUR | -55.68% |
| 2017 Q4 | 324 Thousand EUR | -59.5% |
| 2017 Q3 | 800 Thousand EUR | 0.0% |
| 2017 Q2 | 800 Thousand EUR | 0.0% |
| 2017 Q1 | 800 Thousand EUR | 9.44% |
| 2016 Q2 | 600 Thousand EUR | 20.0% |
| 2016 Q4 | 731 Thousand EUR | 46.2% |
| 2016 Q3 | 500 Thousand EUR | -16.67% |
| 2016 Q1 | 500 Thousand EUR | 4.17% |
| 2016 FY | 731 Thousand EUR | 52.29% |
| 2015 Q4 | 480 Thousand EUR | 20.0% |
| 2015 Q2 | 500 Thousand EUR | -16.67% |
| 2015 Q3 | 400 Thousand EUR | -20.0% |
| 2015 Q1 | 600 Thousand EUR | -22.38% |
| 2015 FY | 480 Thousand EUR | -37.9% |
| 2014 Q2 | 1.3 Million EUR | 0.0% |
| 2014 FY | 773 Thousand EUR | -40.77% |
| 2014 Q3 | 1 Million EUR | -23.08% |
| 2014 Q4 | 773 Thousand EUR | -22.7% |
| 2014 Q1 | 1.3 Million EUR | -0.38% |
| 2013 Q1 | 1.2 Million EUR | -12.15% |
| 2013 Q3 | 1 Million EUR | 0.0% |
| 2013 Q2 | 1 Million EUR | -16.67% |
| 2013 Q4 | 1.3 Million EUR | 30.5% |
| 2013 FY | 1.3 Million EUR | -4.47% |
| 2012 FY | 1.36 Million EUR | 185.77% |
| 2012 Q4 | 1.36 Million EUR | 0.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q3 | - EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q4 | 478 Thousand EUR | 0.0% |
| 2011 FY | 478 Thousand EUR | -67.44% |
| 2011 Q1 | - EUR | -100.0% |
| 2010 FY | 1.46 Million EUR | -46.23% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 Q4 | 1.46 Million EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2009 Q4 | 2.73 Million EUR | 0.0% |
| 2009 FY | 2.73 Million EUR | 23.14% |
| 2008 FY | 2.21 Million EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cegedim SA | 188.54 Million EUR | 94.67% |
| Guerbet SA | 360.51 Million EUR | 97.212% |
| Nexus AG | 15.43 Million EUR | 34.901% |
| Bastide Le Confort Médical SA | 291.04 Million EUR | 96.547% |
| Drägerwerk AG & Co. KGaA | 257.71 Million EUR | 96.1% |
| Sartorius Aktiengesellschaft | 5.02 Billion EUR | 99.8% |
| LNA Santé SA | 341.16 Million EUR | 97.054% |
| Siemens Healthineers AG | 436 Million EUR | 97.695% |
| Medios AG | 14.65 Million EUR | 31.423% |
| Equasens Société anonyme | 39.51 Million EUR | 74.568% |
| Stratec SE | 80.8 Million EUR | 87.562% |